Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -15.157% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. CC1CC(C)(C)NC(=S)N1CCC(=O)NCc1ccc(Cl)cc1
b. COCCNC(=O)Cn1ncc2ccsc2c1=O
c. CCCCN(CCCC)CC(O)Cn1c2ccccc2c(=O)c2ccccc21
d. COc1ccc(-c2nc(CS(=O)(=O)CC(=O)NC3CCC(C)CC3)c(C)o2)cc1
Answer: a. CC1CC(C)(C)NC(=S)N1CCC(=O)NCc1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CC(C)(C)NC(=S)N1CCC(=O)NCc1ccc(Cl)cc1
CC1CC(C)(C)NC(=S)N1CCC(=O)NCc1ccc(Cl)cc1
N-[(4-chlorophenyl)methyl]-3-(4,4,6-trimethyl-2-sulfanylidene-1,3-diazinan-1-yl)propanamide